Evidence map›Paper›PMID 32979936›Full record

ReviewLancet (London, England)2020

Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe.

Emeline Han, Melisa Mei Jin Tan, Eva Turk, Devi Sridhar, Gabriel M Leung, Kenji Shibuya, Nima Asgari, Juhwan Oh, Alberto L García-Basteiro, Johanna Hanefeld and 7 more

Abstract readReview
In one paragraph

Review in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 386 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
386citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

386 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

326 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Emeline HanSaw Swee Hock School of Public Health, National University of Singapore, Singapore.
Melisa Mei Jin TanSaw Swee Hock School of Public Health, National University of Singapore, Singapore.
Eva TurkDepartment of Nursing and Health Sciences, University of South East Norway, Drammen, Norway; Medical Faculty, University of Maribor, Maribor, Slovenia.
Devi SridharCollege of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.
Gabriel M LeungLKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Kenji ShibuyaInstitute for Population Health, King's College London, London, UK.
Nima AsgariAsia Pacific Observatory on Health Systems and Policies, World Health Organization Regional Office for South-East Asia, New Delhi, India.
Juhwan OhCollege of Medicine, Seoul National University, Seoul, South Korea.
Alberto L García-BasteiroISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de InvestigaÇão em SaÚde de ManhiÇa, Maputo, Mozambique.
Johanna HanefeldDepartment of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK; Centre for International Health Protection, Robert Koch Institute, Berlin, Germany.
Alex R CookSaw Swee Hock School of Public Health, National University of Singapore, Singapore.
Li Yang HsuSaw Swee Hock School of Public Health, National University of Singapore, Singapore.
Yik Ying TeoSaw Swee Hock School of Public Health, National University of Singapore, Singapore.
David HeymannDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Helen ClarkThe Helen Clark Foundation, Auckland, New Zealand.
Martin McKeeDepartment of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.
Helena Legido-QuigleySaw Swee Hock School of Public Health, National University of Singapore, Singapore; Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: ephhlq@nus.edu.sg.

Funding

World Health Organization 001
6 · The paper itself

Abstract

The COVID-19 pandemic is an unprecedented global crisis. Many countries have implemented restrictions on population movement to slow the spread of severe acute respiratory syndrome coronavirus 2 and prevent health systems from becoming overwhelmed; some have instituted full or partial lockdowns. However, lockdowns and other extreme restrictions cannot be sustained for the long term in the hope that there will be an effective vaccine or treatment for COVID-19. Governments worldwide now face the common challenge of easing lockdowns and restrictions while balancing various health, social, and economic concerns. To facilitate cross-country learning, this Health Policy paper uses an adapted framework to examine the approaches taken by nine high-income countries and regions that have started to ease COVID-19 restrictions: five in the Asia Pacific region (ie, Hong Kong [Special Administrative Region], Japan, New Zealand, Singapore, and South Korea) and four in Europe (ie, Germany, Norway, Spain, and the UK). This comparative analysis presents important lessons to be learnt from the experiences of these countries and regions. Although the future of the virus is unknown at present, countries should continue to share their experiences, shield populations who are at risk, and suppress transmission to save lives.

Indexed as

Health PolicyAsia, EasternCommerceCommunicable Disease ControlCoronavirus InfectionsCOVID-19EuropeHumansNew ZealandPandemicsPneumonia, Viral

Identifiers

PMID32979936
PMCPMC7515628

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.